04/15/2024
6:57 AM | NGM Biopharmaceuticals (Filer)
| Form 15-12G | |
04/08/2024
11:15 PM | NGM Biopharmaceuticals (Filer)
| Form EFFECT | |
04/08/2024
7:02 PM | GOEDDEL DAVID V (Reporting)
NGM Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
7:03 PM | Column Group II GP, LP (Reporting)
COLUMN GROUP II, LP (Reporting)
COLUMN GROUP L P (Reporting)
Column Group Management LP (Reporting)
Kutzkey Tim (Reporting)
NGM Biopharmaceuticals (Issuer)
Ponoi Capital II, LP (Reporting)
PONOI CAPITAL, LP (Reporting)
Ponoi II Management, LLC (Reporting)
Ponoi Management, LLC (Reporting)
Svennilson Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
7:04 PM | COLUMN GROUP GP, LP (Reporting)
COLUMN GROUP III GP, LP (Reporting)
COLUMN GROUP III, LP (Reporting)
COLUMN GROUP III-A, LP (Reporting)
Column Group IV GP, LP (Reporting)
Column Group IV, LP (Reporting)
Column Group IV-A, LP (Reporting)
Column Group Opportunity III GP, LP (Reporting)
Column Group Opportunity III, LP (Reporting)
NGM Biopharmaceuticals (Issuer)
TCG IV GP, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
7:05 PM | NGM Biopharmaceuticals (Issuer)
TCG Opportunity III GP, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:12 PM | Hooper Suzanne Sawochka (Reporting)
NGM Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/08/2024
3:12 PM | Guyer Shelly D (Reporting)
NGM Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:14 PM | Ho Carole (Reporting)
NGM Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:14 PM | NGM Biopharmaceuticals (Issuer)
Perlich Irene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:14 PM | NGM Biopharmaceuticals (Issuer)
WOODHOUSE DAVID J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:14 PM | NGM Biopharmaceuticals (Issuer)
Viret Jean-Frederic (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:16 PM | NGM Biopharmaceuticals (Issuer)
RIEFLIN WILLIAM JL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:18 PM | NGM Biopharmaceuticals (Issuer)
Pierce Valerie L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
9:51 AM | NGM Biopharmaceuticals (Filer)
| Form S-8 POS | |
04/05/2024
9:52 AM | NGM Biopharmaceuticals (Filer)
| Form S-8 POS | |
04/05/2024
9:53 AM | NGM Biopharmaceuticals (Filer)
| Form S-8 POS | |
04/05/2024
9:53 AM | NGM Biopharmaceuticals (Filer)
| Form S-8 POS | |
04/05/2024
9:54 AM | NGM Biopharmaceuticals (Filer)
| Form S-8 POS | |
04/05/2024
9:55 AM | COLUMN GROUP L P (Filed by)
NGM Biopharmaceuticals (Subject)
| Form SC 13D/A | |
04/05/2024
10:22 AM | Nasdaq Stock Market LLC (Filed by)
NGM Biopharmaceuticals (Subject)
| Form 25-NSE | |
04/05/2024
9:40 AM | NGM Biopharmaceuticals (Filer)
| Form POS AM | |
04/05/2024
9:10 AM | NGM Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
8:48 AM | COLUMN GROUP L P (Filed by)
NGM Biopharmaceuticals (Subject)
| Form SC TO-T/A | |
04/05/2024
8:24 AM | NGM Biopharmaceuticals (Subject)
| Form SC 14D9/A | |
04/05/2024
8:27 AM | NGM Biopharmaceuticals (Subject)
| Form SC 13E3/A | |
04/04/2024
3:42 PM | NGM Biopharmaceuticals (Filer)
| Form 10-K/A | |
03/29/2024
3:56 PM | NGM Biopharmaceuticals (Subject)
| Form SC 14D9/A | |
03/22/2024
4:30 PM | COLUMN GROUP L P (Filed by)
NGM Biopharmaceuticals (Subject)
| Form SC TO-T/A | |
03/22/2024
4:19 PM | NGM Biopharmaceuticals (Subject)
| Form SC 13E3/A | |
03/22/2024
4:21 PM | NGM Biopharmaceuticals (Subject)
| Form SC 14D9/A | |
03/08/2024
4:32 PM | NGM Biopharmaceuticals (Subject)
| Form SC 13E3 | |
03/08/2024
4:21 PM | NGM Biopharmaceuticals (Subject)
| Form SC 14D9 | |
03/08/2024
3:53 PM | COLUMN GROUP L P (Filed by)
NGM Biopharmaceuticals (Subject)
| Form SC TO-T | |
02/26/2024
4:11 PM | NGM Biopharmaceuticals (Subject)
| Form SC14D9C | |
02/26/2024
4:16 PM | COLUMN GROUP L P (Filed by)
NGM Biopharmaceuticals (Subject)
| Form SC 13D/A | |
02/14/2024
5:12 PM | EcoR1 Capital, LLC (Filed by)
NGM Biopharmaceuticals (Subject)
| Form SC 13G/A | |
01/22/2024
5:09 AM | NGM Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
5:01 PM | NGM Biopharmaceuticals (Issuer)
WOODHOUSE DAVID J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
5:02 PM | NGM Biopharmaceuticals (Issuer)
Pierce Valerie L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
5:02 PM | NGM Biopharmaceuticals (Issuer)
Perlich Irene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad) Don't Buy Bullion or Mining Stocks. Do THIS Instead
As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea. Click here to find out what to do. |
01/18/2024
5:03 PM | Lieu Hsiao D (Reporting)
NGM Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
6:30 AM | NGM Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
4:19 PM | NGM Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
3:27 PM | NGM Biopharmaceuticals (Issuer)
Viret Jean-Frederic (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
3:33 PM | COLUMN GROUP L P (Reporting)
NGM Biopharmaceuticals (Issuer)
TCG Opportunity III GP, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
3:25 PM | GOEDDEL DAVID V (Reporting)
NGM Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
3:28 PM | Column Group II GP, LP (Reporting)
COLUMN GROUP II, LP (Reporting)
COLUMN GROUP L P (Reporting)
Column Group Management LP (Reporting)
Kutzkey Tim (Reporting)
NGM Biopharmaceuticals (Issuer)
Ponoi Capital II, LP (Reporting)
PONOI CAPITAL, LP (Reporting)
Ponoi II Management, LLC (Reporting)
Ponoi Management, LLC (Reporting)
Svennilson Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
3:30 PM | COLUMN GROUP GP, LP (Reporting)
COLUMN GROUP III, LP (Reporting)
COLUMN GROUP III-A, LP (Reporting)
Column Group IV GP, LP (Reporting)
Column Group IV, LP (Reporting)
Column Group IV-A, LP (Reporting)
COLUMN GROUP L P (Reporting)
Column Group Opportunity III GP, LP (Reporting)
Column Group Opportunity III, LP (Reporting)
NGM Biopharmaceuticals (Issuer)
TCG IV GP, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
5:08 PM | Lieu Hsiao D (Reporting)
NGM Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
5:09 PM | NGM Biopharmaceuticals (Issuer)
WOODHOUSE DAVID J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
5:11 PM | NGM Biopharmaceuticals (Issuer)
Perlich Irene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
5:12 PM | NGM Biopharmaceuticals (Issuer)
Pierce Valerie L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
5:13 PM | NGM Biopharmaceuticals (Issuer)
Viret Jean-Frederic (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
3:12 PM | NGM Biopharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/17/2023
4:28 PM | NGM Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
1:34 PM | BlackRock Inc. (Filed by)
NGM Biopharmaceuticals (Subject)
| Form SC 13G/A | |
09/18/2023
4:45 PM | NGM Biopharmaceuticals (Issuer)
Perlich Irene (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/06/2023
11:15 PM | NGM Biopharmaceuticals (Filer)
| Form EFFECT | |
08/03/2023
3:11 PM | NGM Biopharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/08/2023
5:31 AM | NGM Biopharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/08/2023
5:06 AM | NGM Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2023
4:50 PM | GOEDDEL DAVID V (Reporting)
NGM Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2023
4:51 PM | Hooper Suzanne Sawochka (Reporting)
NGM Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2023
4:52 PM | NGM Biopharmaceuticals (Issuer)
RIEFLIN WILLIAM JL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2023
4:54 PM | Guyer Shelly D (Reporting)
NGM Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2023
4:48 PM | Ho Carole (Reporting)
NGM Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2023
4:49 PM | NGM Biopharmaceuticals (Issuer)
PERLMUTTER ROGER M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
